Ebola playI got this in an email, the stock looks strong, what do you think? Please ask Dr. KSS.
See the first link. After an exhaustive search I found the ultimate Ebola play and one that will actually make a difference in containing this dreaded disease. When the head of the FDA comes down to your shop and asks you to make an Ebola detector, what do you think that means?! Plus, unlike anything else (current detectors take days for a diagnosis, this will take 20 minutes) OSUR uses a saliva test. Africans don’t like needles that could cause accidental needle pricks, who does ; this could quadruple over night and it just started to take off. Do your DD and buy. Pass this along.
http://www.mcall.com/business/mc-orasure-fda-visit-20141014-story.html
This is a discussion topic or guest posting submitted by a Stock Gumshoe reader. The content has not been edited or reviewed by Stock Gumshoe, and any opinions expressed are those of the author alone.
When Aids was the great concern in the world, particularly Africa, Orasure Company produced a system for easy and efficient diagnosis.
A swab of the oral mucosa was all that was needed. This was relatively inexpensive
but was hampered by the necessity of lab facilities to analyze the swab results.
I have previously postulated the possibility of utilizing the same platform for early
diagnosis of Ebola.
I have held shares of Orasure for several years, just to watch the activity in the firm.
The recent activity and rise in share price indicate that there is a possibility of adapting their proprietory system to the Ebola problem. Worth watching. Dr. Henry Chakoian,AKA Herach
and quick diagnosis of Ebola. I have noticed an unusual activity in the
As I see it, and I don’t mean to burst anyone’s balloons, Orasure is not at all a way to invest in Ebola concern and will not rise. To assert that “this could quadruple overnight”? That merely makes me think of a clip from “Wayne’s World.”
https://www.youtube.com/watch?v=QOKociU8t_Q
Orasure’s methodology is antibody detection in saliva. Which makes it useless for Ebola. Such testing is only relevant for viruses that take on chronic states, such as HIV, HCV or sometimes HBV. It can take weeks for antibody to emerge. For example, if a health worker gets a deep needlestick injury from a needle used on an HCV patient, the worker’s blood will first show HCV RNA two weeks later, but not show antibody for 4-6 months. By the time an Orasure test for Ebola would turn positive, the virus has already ridden roughshod over the patient in question and has either killed that person or moved on.
Even if the methodology were not hopelessly not applicable to Ebola, the cost of an Orasure test is abou $40, which makes it prohibitively expensive for a continent that cannot afford soap and towels in hospitals.
The way to detect Ebola early involves picking up the RNA and determining that it in fact is Ebola RNA. There will not be a reasonable way to do that on saliva in some quick turnaround manner, and in fact saliva contains RNA-degrading enzymes as well. Saliva tests for HIV and HCV RNA have met with entrepreneurs trying to contrive them, and have failed.
I would not buy shares in Orasure. It is mainly a means of privately doing a test at home for something devastating but chronic where you may not prefer authorities being notified.
I don’t think that would be a likely analogy Dr. KSS. Have you seen some of the Ebola plays? LAKE for instance, went from $6.50, close to where I bought it, and rapidly went to $29 or so (I got out at $27). Overnight is hyperbole, a week is reality.
Also, why then did the head of the FDA request a detector from OSCUR? Wouldn’t she know about the difficulties you explain? Please explain that, assuming of course the video story was true.
http://www.mcall.com/business/mc-orasure-fda-visit-20141014-story.html
I would not compare my background and minimal expertise to that of Dr. KSS.
The Orasure swab is for mucosa, not saliva.The cost factor is negligible when compared to the cost, over $100,000, to sanitize one apartment where a patient with Ebola has resided. The application in the field, any portion of Africa, Airline terminals and other areas of concern make this process ubiquitous.
I am not qualified to recommend investing in Orasure or any other shares I intended to call your attention to one platform which might have possibilities in early diagnosis of Ebola. Dr. Henry M. Chakoian, AKA Herach
who exactly was that email from? what outfit?